Tempus Wealth Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
6,252
+195
+3% +$66.8K 0.44% 58
2026
Q1
$2.13M Sell
6,057
-45
-0.7% -$16K 0.49% 52
2025
Q4
$2M Sell
6,102
-140
-2% -$44.4K 0.46% 51
2025
Q3
$1.76M Buy
6,242
+137
+2% +$39.7K 0.4% 61
2025
Q2
$1.7M Buy
6,105
+154
+3% +$43.6K 0.42% 63
2025
Q1
$1.85M Sell
5,951
-51
-0.8% -$15.1K 0.55% 46
2024
Q4
$1.56M Buy
6,002
+484
+9% +$144K 0.48% 55
2024
Q3
$1.78M Buy
5,518
+228
+4% +$74.6K 0.65% 38
2024
Q2
$1.65M Buy
5,290
+116
+2% +$34.1K 0.69% 34
2024
Q1
$1.47M Buy
5,174
+35
+0.7% +$10.2K 0.65% 36
2023
Q4
$1.48M Sell
5,139
-76
-1% -$20.7K 0.65% 43
2023
Q3
$1.4M Sell
5,215
-3
-0.1% -$749 0.7% 29
2023
Q2
$1.16M Buy
5,218
+175
+3% +$40.6K 0.52% 56
2023
Q1
$1.22M Buy
5,043
+48
+1% +$11.8K 0.6% 42
2022
Q4
$1.31M Sell
4,995
-211
-4% -$56.6K 0.8% 28
2022
Q3
$1.17M Buy
5,206
+519
+11% +$126K 0.78% 35
2022
Q2
$1.14M Sell
4,687
-193
-4% -$47.3K 0.94% 25
2022
Q1
$1.18M Sell
4,880
-1,205
-20% -$277K 0.84% 33
2021
Q4
$1.37M Buy
6,085
+350
+6% +$73.9K 0.74% 35
2021
Q3
$1.22M Buy
5,735
+585
+11% +$135K 0.69% 38
2021
Q2
$1.25M Buy
5,150
+3,082
+149% +$758K 0.83% 32
2021
Q1
$515K Buy
2,068
+377
+22% +$90K 0.55% 44
2020
Q4
$389K Buy
1,691
+212
+14% +$48.9K 0.5% 43
2020
Q3
$376K Sell
1,479
-133
-8% -$32.9K 0.54% 38
2020
Q2
$380K Sell
1,612
-54
-3% -$12.3K 0.57% 35
2020
Q1
$338K Buy
1,666
+55
+3% +$12K 0.55% 33
2019
Q4
$388K Buy
+1,611
New +$355K 0.34% 44

Other funds holding AMGN

Tempus Wealth Planning's AMGN Position: Q2 2026 in Review

Tempus Wealth Planning increased its Amgen (AMGN) stake by 3.2% in Q2 2026, buying an estimated $66.8K and bringing the position to 6,252 shares worth $2.26M. The position accounts for 0.44% of the portfolio, ranked #58.

Tempus Wealth Planning first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tempus Wealth Planning held 6,252 shares of Amgen worth $2.26M as of Q2 2026.
  • Tempus Wealth Planning bought 195 Amgen shares in Q2 2026, an estimated $66.8K.
  • Amgen made up 0.44% of Tempus Wealth Planning's portfolio in Q2 2026, its #58 holding.
  • Tempus Wealth Planning first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.